MM

Matthew W. Martin

FT Forma Therapeutics: 50 patents #2 of 86Top 3%
AM Amgen: 10 patents #315 of 2,867Top 15%
VH Valo Health: 8 patents #9 of 53Top 20%
VD Valo Early Discovery: 5 patents #11 of 30Top 40%
HI H. Lee Moffitt Cancer Center And Research Institute: 1 patents #146 of 269Top 55%
TU Trustees Of Indiana University: 1 patents #114 of 337Top 35%
📍 Indianapolis, IN: #18 of 5,011 inventorsTop 1%
🗺 Indiana: #128 of 33,936 inventorsTop 1%
Overall (All Time): #26,123 of 4,157,543Top 1%
74
Patents All Time

Issued Patents All Time

Showing 1–25 of 74 patents

Patent #TitleCo-InventorsDate
12409173 Repurposing FDA-approved drugs as a novel cancer therapeutic avenue through inhibition of PRMT5 Tao Lu, Lakshmi Milind PRABHU 2025-09-09
12264137 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2025-04-01
12049466 Fused bicyclic compounds useful as ubiquitin-specific peptidase 30 inhibitors Alexandre Joseph Buckmelter 2024-07-30
11919839 Alpha-cinnamide compounds and compositions as HDAC8 inhibitors Kenneth W. Bair, Nicholas Barczak, Bingsong Han, David R. Lancia, Jr., Cuixian Liu +5 more 2024-03-05
11891365 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2024-02-06
11814386 Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors Alex J. Buckmelter, Justin Andrew Caravella, Hongbin Li, Steven Mischke, David Richard +1 more 2023-11-14
11535618 Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors Alex J. Buckmelter, Justin Andrew Caravella, Hongbin Li, Steven Mischke, David Richard +1 more 2022-12-27
11535607 Isoindolines as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Jennifer R. Thomason, Bingsong Han, Aleksandra Rudnitskaya +1 more 2022-12-27
11345672 Methods using HDAC11 inhibitors Jennifer Lee, Nicholas Barczak, Jaime Escobedo, Chiara Conti, Bingsong Han +6 more 2022-05-31
11299484 Inhibiting fatty acid synthase (FASN) Mary-Margaret Zablocki, Scot Richard Mente, Christopher J. Dinsmore, Zhongguo Wang, Xiaozhang Zheng 2022-04-12
11279681 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +5 more 2022-03-22
11274085 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2022-03-15
11274084 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2022-03-15
11267805 Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanone George P. Luke, Stephen Hubbs, Shawn Schiller, Robert Wenslow, Yawei Shi +1 more 2022-03-08
11247987 Inhibiting ubiquitin specific peptidase 30 Justin Andrew Caravella, Bingsong Han, Cuixian Liu, Stephanos Ioannidis, Alexandre Joseph Buckmelter +3 more 2022-02-15
11111229 Tetrahydroquinoline compositions as BET bromodomain inhibitors Kenneth W. Bair, Torsten Herbertz, Goss S. Kauffman, Katherine J. Kayser-Bricker, George P. Luke +3 more 2021-09-07
11084831 Benzopiperazine compositions as BET bromodomain inhibitors Kenneth W. Bair, Torsten Herbertz, Goss S. Kauffman, Katherine J. Kayser-Bricker, George P. Luke +4 more 2021-08-10
10995078 Compounds and compositions for inhibition of FASN Kenneth W. Bair, David R. Lancia, Jr., Hongbin Li, James Loch, Wei Lu +3 more 2021-05-04
10988441 Alpha-cinnamide compounds and compositions as HDAC8 inhibitors Kenneth W. Bair, Nicholas Barczak, Bingsong Han, David R. Lancia, Jr., Cuixian Liu +5 more 2021-04-27
10988450 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +6 more 2021-04-27
10875848 Inhibiting fatty acid synthase (FASN) Mary-Margaret Zablocki, Scot Richard Mente, Christopher J. Dinsmore, Zhongguo Wang, Xiaozhang Zheng 2020-12-29
10829461 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2020-11-10
10829462 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +5 more 2020-11-10
10822316 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Xiaozhang Zheng, Pui Yee Ng, Bingsong Han, Jennifer R. Thomason, Mary-Margaret Zablocki +4 more 2020-11-03
10800750 Compounds and compositions for inhibition of FASN Kenneth W. Bair, David R. Lancia, Jr., Hongbin Li, James Loch, Wei Lu +3 more 2020-10-13